Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67915-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- DDX3 antibody
- Antibody type
- Monoclonal
- Description
- DDX3 antibody (Cat. #67915-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D3A1
- Vial size
- 20ul, 150ul
Submitted references An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice.
DDX3 Regulates the Cap-Independent Translation of the Japanese Encephalitis Virus via Its Interactions with PABP1 and the Untranslated Regions of the Viral Genome.
A novel stroke rehabilitation strategy and underlying stress granule regulations through inhibition of NLRP3 inflammasome activation.
Bortezomib induces cell apoptosis and increases the efficacy of αPD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1.
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Yu H, Yang Y, Lin P, Liu C, Wen Y, Huang Z, Fang Z, Hu Z, Huang S
Nature communications 2026 Feb 26;17(1)
Nature communications 2026 Feb 26;17(1)
DDX3 Regulates the Cap-Independent Translation of the Japanese Encephalitis Virus via Its Interactions with PABP1 and the Untranslated Regions of the Viral Genome.
Li C, Zhang L, Tang C, Chen X, Shi J, Li Q, Jiao X, Guo J, Wang B, Bu K, Wahaab A, Yuan Y, Sun MA, Li Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jul;12(27):e2502493
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jul;12(27):e2502493
A novel stroke rehabilitation strategy and underlying stress granule regulations through inhibition of NLRP3 inflammasome activation.
Wang Q, Kohls W, Wills M, Li F, Pang Q, Geng X, Ding Y
CNS neuroscience & therapeutics 2024 Jan;30(1):e14405
CNS neuroscience & therapeutics 2024 Jan;30(1):e14405
Bortezomib induces cell apoptosis and increases the efficacy of αPD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1.
Jiang F, Liu W, Zhou Y, Lin S, Zhang Q, Zhang W, Xue Y, Li C, Gao A, Shao M, Liao S, Ma T, Yu X
International immunopharmacology 2024 Dec 25;143(Pt 2):113311
International immunopharmacology 2024 Dec 25;143(Pt 2):113311
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Đukić N, Strømland Ø, Elsborg JD, Munnur D, Zhu K, Schuller M, Chatrin C, Kar P, Duma L, Suyari O, Rack JGM, Baretić D, Crudgington DRK, Groslambert J, Fowler G, Wijngaarden S, Prokhorova E, Rehwinkel J, Schüler H, Filippov DV, Sanyal S, Ahel D, Nielsen ML, Smith R, Ahel I
Science advances 2023 Sep 15;9(37):eadi2687
Science advances 2023 Sep 15;9(37):eadi2687
No comments: Submit comment
No validations: Submit validation data